Angiotensin-converting enzyme 2: virus accomplice or host defender?

被引:0
作者
Wang Jiyan [1 ]
Chang Hongkai [1 ]
Qiao Yaya [1 ]
Sun Huanran [1 ]
Li Xichuan [6 ]
Yuan Shuofeng [10 ]
Zhang Shuai [17 ]
Shan Changliang [1 ]
机构
[1] State Key Laboratory of Emerging Infectious Diseases
[2] Carol Yu Centre for Infection  12. Department of Microbiology  13. Li Ka Shing Faculty of Medicine 
[3] School of Integrative Medicine
[4] Tianjin University of Traditional Chinese Medicine  19. Tianjin 301617
[5] State Key Laboratory of Medicinal Chemical Biology
[6] College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research  3. Nankai University  4. Tianjin 300350 
[7] Tianjin Key Laboratory of Animal and Plant Resistance
[8] College of Life Sciences  8. Tianjin Normal University  9. Tianjin 300387
关键词
ACE2; asymptomatic infection; COVID-19; metabolism; SARS-CoV-2;
D O I
暂无
中图分类号
R511 [病毒传染病];
学科分类号
100401 ;
摘要
Objective: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to social disruptions, mainly because we know too little about SARS-CoV-2.Methods and Results: In this study, we integrated RNA sequencing results and found that SARS-CoV-2 infection alters aerobic glycolysis, the oxidative pentose phosphate pathway (oxiPPP), and DNA replication in lung tissues and cells. However, the direction of metabolic flux and DNA replication are dominated by angiotensin-converting enzyme 2 (ACE2), a host cell-expressed viral receptor protein. More interestingly, although hosts with a high expression of ACE2 are more likely to be infected with SARS-CoV-2, the invading virus cannot perform nucleic acid replication well due to the restriction of glucose metabolism, eventually resulting in a prolonged infection cycle or infection failure.Conclusion: Our findings preliminarily explain the reasons for the emergence of asymptomatic infections at an early stage, which will provide assistance for the development of detection methods for diagnosing COVID-19.
引用
收藏
相关论文
共 50 条
  • [21] SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
    Felber, Randy
    New, William
    Riskin, Suzanne I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [22] Angiotensin-converting enzyme inhibitor/angiotensinIIreceptor blocker treatment and haemodynamic factors are associated with increased cardiacmRNAexpression of angiotensin-converting enzyme2in patients with cardiovascular disease
    Lebek, Simon
    Tafelmeier, Maria
    Messmann, Rebecca
    Provaznik, Zdenek
    Schmid, Christof
    Maier, Lars S.
    Birner, Christoph
    Arzt, Michael
    Wagner, Stefan
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2248 - 2257
  • [23] Vascular Angiotensin-Converting Enzyme 2 Lord of the Ring?
    Batlle, Daniel
    Wysocki, Jan
    Khan, Mirza S.
    CIRCULATION RESEARCH, 2010, 107 (07) : 822 - 824
  • [24] Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
    Gu, Hongjing
    Xie, Zhengde
    Li, Tieling
    Zhang, Shaogeng
    Lai, Chengcai
    Zhu, Ping
    Wang, Keyu
    Han, Lina
    Duan, Yueqiang
    Zhao, Zhongpeng
    Yang, Xiaolan
    Xing, Li
    Zhang, Peirui
    Wang, Zhouhai
    Li, Ruisheng
    Yu, Jane J.
    Wang, Xiliang
    Yang, Penghui
    SCIENTIFIC REPORTS, 2016, 6
  • [25] Angiotensin-converting enzyme 2 in dogs with Dirofilaria immitis
    Adin, Darcy B.
    Spalla, Meaghan
    Walden, Heather
    Gruntmeir, Jeff
    Hernandez, Jorge A.
    Long, Maureen
    PARASITES & VECTORS, 2023, 16 (01)
  • [26] New perspectives on angiotensin-converting enzyme 2 and its related diseases
    Liu, Li-Ping
    Zhang, Xiao-Li
    Li, Jian
    WORLD JOURNAL OF DIABETES, 2021, 12 (06)
  • [27] Angiotensin-Converting Enzyme 2-Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators Studies In Vivo, Ex Vivo, and In Vitro
    Haber, Philipp K.
    Ye, Minghao
    Wysocki, Jan
    Maier, Christoph
    Haque, Syed K.
    Batlle, Daniel
    HYPERTENSION, 2014, 63 (04) : 774 - 782
  • [28] COVID-19: relationship between angiotensin-converting enzyme 2, cardiovascular system and host immune response
    Bevacqua, Raul J.
    Perrone, Sergio, V
    INSUFICIENCIA CARDIACA, 2020, 15 (02) : 34 - 51
  • [29] Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
    Pathangey, Girish
    Fadadu, Priyal P.
    Hospodar, Alexandra R.
    Abbas, Amr E.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 320 (03) : L301 - L330
  • [30] Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity
    Saulnier, Nathalie M.
    Thorne, Devyn M.
    Bablu, Fariha E.
    Suzuki, Alessia M.
    Khan, Rafa L.
    Oliveira, Katelin X.
    Suzuki, Yuichiro J.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 761